S-Protected Thiolated Chitosan versus Thiolated Chitosan as Cell Adhesive Biomaterials for Tissue Engineering.


Journal

ACS applied materials & interfaces
ISSN: 1944-8252
Titre abrégé: ACS Appl Mater Interfaces
Pays: United States
ID NLM: 101504991

Informations de publication

Date de publication:
30 Aug 2023
Historique:
medline: 1 9 2023
pubmed: 18 8 2023
entrez: 18 8 2023
Statut: ppublish

Résumé

Chitosan (Ch) and different Ch derivatives have been applied in tissue engineering (TE) because of their biocompatibility, favored mechanical properties, and cost-effectiveness. Most of them, however, lack cell adhesive properties that are crucial for TE. In this study, we aimed to design an S-protected thiolated Ch derivative exhibiting high cell adhesive properties serving as a scaffold for TE. 3-((2-Acetamido-3-methoxy-3-oxopropyl)dithio) propanoic acid was covalently attached to Ch via a carbodiimide-mediated reaction. Low-, medium-, and high-modified Chs (Ch-SS-1, Ch-SS-2, and Ch-SS-3) with 54, 107 and 140 μmol of ligand per gram of polymer, respectively, were tested. In parallel, three thiolated Chs, namely Ch-SH-1, Ch-SH-2, and Ch-SH-3, were prepared by conjugating

Identifiants

pubmed: 37594415
doi: 10.1021/acsami.3c09337
pmc: PMC10472333
doi:

Substances chimiques

Chitosan 9012-76-4
Biocompatible Materials 0
Acetylcysteine WYQ7N0BPYC
Carbodiimides 0
Cryogels 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

40304-40316

Références

J Glaucoma. 2014 Oct-Nov;23(8 Suppl 1):S20-3
pubmed: 25275899
J Biol Chem. 1999 Jan 22;274(4):2416-23
pubmed: 9891011
FASEB J. 2009 Sep;23(9):2956-67
pubmed: 19403512
Redox Biol. 2014 Jun 13;2:803-13
pubmed: 25009782
Science. 1999 Aug 13;285(5430):1028-32
pubmed: 10446041
Trends Biotechnol. 2012 Apr;30(4):185-90
pubmed: 22260747
Biomimetics (Basel). 2022 Oct 04;7(4):
pubmed: 36278708
Arterioscler Thromb Vasc Biol. 2002 Aug 1;22(8):1354-9
pubmed: 12171800
J Biomed Mater Res A. 2022 Feb;110(2):266-272
pubmed: 34331513
Adv Drug Deliv Rev. 2009 Oct 5;61(12):1020-32
pubmed: 19643155
Theranostics. 2017 Feb 27;7(5):1072-1087
pubmed: 28435449
Adv Drug Deliv Rev. 2005 Nov 3;57(11):1569-82
pubmed: 16176846
Carbohydr Polym. 2017 Jul 1;167:250-258
pubmed: 28433160
Int J Pharm. 2003 Apr 30;256(1-2):183-9
pubmed: 12695025
Anal Chem. 2018 Jun 5;90(11):6867-6876
pubmed: 29746096
J Wound Ostomy Continence Nurs. 1996 Jul;23(4):224-6
pubmed: 8900676
Tissue Eng Part B Rev. 2013 Dec;19(6):485-502
pubmed: 23672709
Int J Mol Sci. 2015 Aug 05;16(8):18149-84
pubmed: 26251901
Biomacromolecules. 2012 Aug 13;13(8):2349-58
pubmed: 22758219
Int Ophthalmol. 2019 Mar;39(3):693-696
pubmed: 29549486
J Tissue Eng. 2022 Sep 29;13:20417314221122121
pubmed: 36199979
Biomaterials. 2011 Sep;32(26):5979-93
pubmed: 21621838
Carbohydr Polym. 2012 Oct 1;90(2):765-72
pubmed: 22839999
BMC Cancer. 2019 May 22;19(1):479
pubmed: 31117974
J Mol Med (Berl). 2012 Jun;90(6):625-35
pubmed: 22187113
Biomed Res Int. 2015;2015:821279
pubmed: 26504833
J Mater Chem B. 2019 Feb 28;7(8):1186-1208
pubmed: 32255159
J Mater Chem B. 2014 Jun 7;2(21):3161-3184
pubmed: 24999429
J Histochem Cytochem. 2021 Feb;69(2):93-104
pubmed: 32757871
Opt Lett. 2019 Oct 15;44(20):4937-4940
pubmed: 31613233
ACS Appl Mater Interfaces. 2018 Sep 19;10(37):31168-31177
pubmed: 30156819
Carbohydr Polym. 2020 Aug 15;242:116395
pubmed: 32564864
Bioact Mater. 2020 Feb 12;5(1):164-183
pubmed: 32083230
Mater Sci Eng C Mater Biol Appl. 2021 Oct;129:112383
pubmed: 34579902
J Biomed Mater Res A. 2011 Nov;99(2):316-26
pubmed: 21887740
Biophys J. 2015 Apr 7;108(7):1604-1612
pubmed: 25863052
Free Radic Biol Med. 2015 Mar;80:148-57
pubmed: 25433365
Proc Natl Acad Sci U S A. 2019 Jul 16;116(29):14448-14455
pubmed: 31266897
Biomacromolecules. 2021 Jan 11;22(1):24-56
pubmed: 32567846
Biomaterials. 2011 Oct;32(29):6929-45
pubmed: 21762982
J R Soc Interface. 2006 Oct 22;3(10):589-601
pubmed: 16971328
J Mater Chem B. 2013 Jun 7;1(21):2682-2695
pubmed: 32260973
Carbohydr Polym. 2020 Feb 15;230:115710
pubmed: 31887922
J Biol Chem. 1983 Dec 10;258(23):14359-65
pubmed: 6643486
Int J Pharm. 2023 Mar 25;635:122753
pubmed: 36863545
Biomaterials. 2001 Nov;22(22):2959-66
pubmed: 11575470

Auteurs

Bao Le-Vinh (B)

Department of Pharmaceutical Technology, Institute of Pharmacy, University of Innsbruck, Innrain 80/82, 6020 Innsbruck, Austria.
Department of Industrial Pharmacy, Faculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh city, 700000 Ho Chi Minh City, Vietnam.

Christian Steinbring (C)

Department of Pharmaceutical Technology, Institute of Pharmacy, University of Innsbruck, Innrain 80/82, 6020 Innsbruck, Austria.

Nguyet-Minh Nguyen Le (NM)

Department of Pharmaceutical Technology, Institute of Pharmacy, University of Innsbruck, Innrain 80/82, 6020 Innsbruck, Austria.
Department of Industrial Pharmacy, Faculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh city, 700000 Ho Chi Minh City, Vietnam.

Barbara Matuszczak (B)

Department of Pharmaceutical Chemistry, Institute of Pharmacy, University of Innsbruck, Innrain 80-82, 6020 Innsbruck, Austria.

Andreas Bernkop-Schnürch (A)

Department of Pharmaceutical Technology, Institute of Pharmacy, University of Innsbruck, Innrain 80/82, 6020 Innsbruck, Austria.

Articles similaires

Organoids Humans Tissue Engineering Coculture Techniques Regenerative Medicine
Organoids Animals Kidney Mice Humans

Folate-engineered chitosan nanoparticles: next-generation anticancer nanocarriers.

Prashant Kesharwani, Kratika Halwai, Saurav Kumar Jha et al.
1.00
Chitosan Humans Folic Acid Nanoparticles Drug Carriers

Personalized bioceramic grafts for craniomaxillofacial bone regeneration.

Ana Beatriz G de Carvalho, Maedeh Rahimnejad, Rodrigo L M S Oliveira et al.
1.00
Humans Bone Regeneration Ceramics Printing, Three-Dimensional Tissue Scaffolds

Classifications MeSH